NYSE: TEVA - Teva Pharmaceutical Industries

Yield per half year: -19.05%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Teva Pharmaceutical Industries

Extended chart Simple chart
Financial Markets by TradingView

About Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. (ивр. ‏טבע תעשיות פרמצבטיות בע"מ‏‎) — транснациональная фармацевтическая компания со штаб-квартирой в Петах-Тикве, Израиль. Компания специализируется на производстве препаратов-дженериков, действующих веществ, и в меньшей степени, собственных препаратов. Компания занимает 16 место в списке крупнейших фармацевтических производителей и 704 место в рейтинге крупнейших мировых компаний Forbes Global 2000. В активе компании находятся 80 заводов, а сама корпорация осуществляет свою деятельность в 60 странах.

more details
Teva является членом американской ассоциации фармацевтических исследователей и производителей.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 1990-03-26
ISIN US8816242098
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 5.57
Дивиденд ао 0.51
Сайт http://www.tevapharm.com
Цена ао 15.7
Change price per day: +1.02% (14.72)
Change price per week: +8.94% (13.65)
Change price per month: -5.23% (15.69)
Change price per 3 month: -31.41% (21.68)
Change price per half year: -19.05% (18.37)
Change price per year: +12.23% (13.25)
Change price per 3 year: +77.23% (8.39)
Change price per 5 year: +45.93% (10.19)
Change price per 10 year: -72.4% (53.87)
Change price per year to date: -32.68% (22.09)
All parameters

Underestimation

Title Value Grade
P/S 1.53 8
P/BV 4.41 4
P/E 872 1
EV/EBITDA -132.09 0
Total: 4.13

Efficiency

Title Value Grade
ROA, % -3.96 0
ROE, % -25.44 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0.4286 4.29
Total: 1.33

Debt

Title Value Grade
Debt/EBITDA -59.67 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % -0.6963 0
Yield Ebitda, % -106.57 0
Yield EPS, % -62.55 0
Total: 0.6
More

More

Institutions Volume Share, %
Blackrock Inc. 41664861 3.72
Ion Asset Management Limited 40327407 3.6
Lingotto Investment Management Llp 34457656 3.07
Phoenix Holdings Ltd. 34383192 3.07
Clal Insurance Enterprises Holdings Ltd 32804131 2.93
Migdal Insurance & Financial Holdings Ltd. 28919540 2.58
Harel Insurance Investments & Financial Services Ltd. 28533099 2.55
Menora Mivtachim Holdings Ltd. 28128744 2.51
Slate Path Capital, LP 26231184 2.34
Rubric Capital Management LP 18226601 1.63

ETFShare, %Profitability for 1 year, %Dividends, %
Fidelity Growth Opportunities ETF 0.24635 -1.24 0.48881
IQ 500 International ETF 0.16121 6.72 4.03885
0.22.742.27



Head Job title Payment Year of birth
Mr. Eliyahu Sharon Kalif Executive VP & CFO 2.01M 1974 (51 year)
Mr. Amir Weiss Senior VP & Chief Accounting Officer N/A 1977 (48 years)
Mr. Mark Sabag Executive Vice President of International Markets Commercial 1.92M 1971 (54 years)
Kathleen Veit Senior Vice President, Global Compliance & Ethics Officer N/A
Mr. Richard D. Francis President, CEO & Director N/A 1968 (57 years)
Ran Meir Head of Investor Relations N/A
Ms. Vikki Conway Acting Head of Global Human Resources N/A 1972 (53 years)
Mr. Richard Gordon Daniell Executive Vice President of European Commercial 1967 (58 years)
Mr. Matthew Shields Executive Vice President of Global Operations 1974 (51 year)
Mr. David R. Mcavoy J.D. Executive VP & Chief Legal Officer 1963 (62 years)

Address: Israel, Tel Aviv, 124 Dvora Hanevi’a Street - open in Google maps, open in Yandex maps
Website: http://www.tevapharm.com